The dengue virus NS1 protein conveys pro-inflammatory signals by docking onto human high-density lipoproteins
暂无分享,去创建一个
E. Harris | F. Rey | B. Raynal | M. Ungeheuer | Xiaokang Zhang | P. Buchy | G. Péhau-Arnaudet | Kyu-Ho Park | F. Coulibaly | F. Bontems | S. Brûlé | J. Voss | S. Petres | P. Dussart | Souheyla Benfrid | Mariano Dellarole | Carole Tamietti | P. England | A. Mikhailova | S. B. Biering | Anavaj Sakunthabaï | V. Duong | M. Flamand | Scott B. Biering | M. Dellarole | Sébastien Brûlé
[1] E. Undurraga,et al. Persistence of symptoms in dengue patients: a clinical cohort study. , 2020, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[2] X. Su,et al. The exchangeable apolipoproteins in lipid metabolism and obesity. , 2020, Clinica chimica acta; international journal of clinical chemistry.
[3] V. Cardoso,et al. Serum lipid profile as a predictor of dengue severity: A systematic review and meta‐analysis , 2019, Reviews in medical virology.
[4] C. Sirois,et al. Inflammatory status and severity of disease in dengue patients are associated with lipoprotein alterations , 2019, PloS one.
[5] E. Harris,et al. Cyclic Dinucleotide–Adjuvanted Dengue Virus Nonstructural Protein 1 Induces Protective Antibody and T Cell Responses , 2019, The Journal of Immunology.
[6] E. Harris,et al. Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism , 2019, Cell reports.
[7] A. Marais. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. , 2019, Pathology.
[8] G. Ogg,et al. Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection , 2018, Nature Communications.
[9] D. Sanoudou,et al. Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis , 2018, Journal of personalized medicine.
[10] E. Harris,et al. The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis. , 2018, Annual review of virology.
[11] C. Mok,et al. Serum Cytokine Profiles in Patients with Dengue Fever at the Acute Infection Phase , 2018, Disease markers.
[12] J. Heinecke,et al. Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions? , 2018, Expert review of proteomics.
[13] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[14] S. Urcuqui-Inchima,et al. [Modulation of high-density lipoprotein and cytokine IL-1β and IL-6 levels in patients with dengue]. , 2018, Revista peruana de medicina experimental y salud publica.
[15] A. Brault,et al. A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model , 2017, Scientific Reports.
[16] G. N. Nascentes,et al. Prospective study of patients with persistent symptoms of dengue in Brazil , 2017, Revista do Instituto de Medicina Tropical de Sao Paulo.
[17] T. Weichhart,et al. Pro- versus Anti-inflammatory Actions of HDLs in Innate Immunity. , 2017, Cell metabolism.
[18] Marion C Lanteri,et al. Serum from dengue virus-infected patients with and without plasma leakage differentially affects endothelial cells barrier function in vitro , 2017, PloS one.
[19] K. Stacey,et al. Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6 , 2017, Immunology and cell biology.
[20] A. Rothman,et al. Immune-mediated cytokine storm and its role in severe dengue , 2017, Seminars in Immunopathology.
[21] K. Abhishek,et al. Association of interleukin-2, -4 and -10 with dengue severity , 2017, Indian journal of pathology & microbiology.
[22] A. Wilder-Smith,et al. Markers of dengue severity: a systematic review of cytokines and chemokines. , 2016, Journal of General Virology.
[23] F. Scholle,et al. Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells. , 2016, Virology.
[24] R. Mohana-Borges,et al. Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins , 2016, Journal of Virology.
[25] Sunit K. Singh,et al. Flavivirus NS1: a multifaceted enigmatic viral protein , 2016, Virology Journal.
[26] E. Harris,et al. Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability , 2016, PLoS pathogens.
[27] C. Kalogeropoulou,et al. Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function. , 2016, Biochemistry.
[28] P. Young,et al. The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design. , 2016, Antiviral research.
[29] G. Dernick,et al. Cholesteryl ester transfer between lipoproteins does not require a ternary tunnel complex with CETP. , 2016, Journal of structural biology.
[30] G. Screaton,et al. Recent advances in understanding dengue , 2016, F1000Research.
[31] Yee‐Shin Lin,et al. Anti-dengue virus nonstructural protein 1 antibodies contribute to platelet phagocytosis by macrophages , 2015, Thrombosis and Haemostasis.
[32] V. Herrera,et al. Characterization of the health condition of people convalescing from a dengue episode. , 2015, Biomedica : revista del Instituto Nacional de Salud.
[33] Anja Boisen,et al. Quantification of NS1 dengue biomarker in serum via optomagnetic nanocluster detection , 2015, Scientific Reports.
[34] D. Hume,et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity , 2015, Science Translational Medicine.
[35] Eva Harris,et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination , 2015, Science Translational Medicine.
[36] A. Sakuntabhai,et al. Value of Routine Dengue Diagnostic Tests in Urine and Saliva Specimens , 2015, PLoS neglected tropical diseases.
[37] E. Harris,et al. Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue Outcome , 2015, PLoS neglected tropical diseases.
[38] Shobini Jayaraman,et al. Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL[S] , 2015, Journal of Lipid Research.
[39] J. Chu,et al. Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection , 2015, PLoS pathogens.
[40] B. Kleuser,et al. The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality , 2015, Biological chemistry.
[41] R. Kuhn,et al. Structure‐guided insights on the role of NS1 in flavivirus infection , 2015, BioEssays : news and reviews in molecular, cellular and developmental biology.
[42] Indra Ramasamy,et al. Recent advances in physiological lipoprotein metabolism , 2014, Clinical chemistry and laboratory medicine.
[43] M. Schittmayer,et al. Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology. , 2014, Progress in lipid research.
[44] S. Vilcarromero,et al. Occurrence and correlates of symptom persistence following acute dengue fever in Peru. , 2014, The American journal of tropical medicine and hygiene.
[45] F. Turrini,et al. Proteomic Analysis of Plasma-Purified VLDL, LDL, and HDL Fractions from Atherosclerotic Patients Undergoing Carotid Endarterectomy: Identification of Serum Amyloid A as a Potential Marker , 2013, Oxidative medicine and cellular longevity.
[46] John S. Brownstein,et al. The global distribution and burden of dengue , 2013, Nature.
[47] M. Saemann,et al. Inflammation alters HDL composition and function: implications for HDL-raising therapies. , 2013, Pharmacology & therapeutics.
[48] G. Ren,et al. Optimized negative-staining electron microscopy for lipoprotein studies. , 2013, Biochimica et biophysica acta.
[49] S. Sekaran,et al. Cytokine Expression Profile of Dengue Patients at Different Phases of Illness , 2012, PloS one.
[50] Sjors H.W. Scheres,et al. RELION: Implementation of a Bayesian approach to cryo-EM structure determination , 2012, Journal of structural biology.
[51] Trai-Ming Yeh,et al. Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation. , 2012, The Journal of infection.
[52] A. Kontush,et al. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.
[53] J. d'Alayer,et al. Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein , 2011, Proceedings of the National Academy of Sciences.
[54] W. Hörl,et al. The versatility of HDL: a crucial anti‐inflammatory regulator , 2010, European journal of clinical investigation.
[55] Ryo Takano,et al. A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection. , 2010, Antiviral research.
[56] J. Suvarna,et al. Serum lipid profile: a predictor of clinical outcome in dengue infection , 2009, Tropical medicine & international health : TM & IH.
[57] K. Ikuta,et al. Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1. , 2007, Biochemical and biophysical research communications.
[58] C. King,et al. Antiplatelet autoantibodies elicited by dengue virus non‐structural protein 1 cause thrombocytopenia and mortality in mice , 2007, Journal of thrombosis and haemostasis : JTH.
[59] A. Falconar. Antibody Responses Are Generated to Immunodominant ELK/KLE-Type Motifs on the Nonstructural-1 Glycoprotein during Live Dengue Virus Infections in Mice and Humans: Implications for Diagnosis, Pathogenesis, and Vaccine Design , 2007, Clinical and Vaccine Immunology.
[60] M. Guzmán,et al. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever‐dengue shock syndrome (DHF/DSS) , 2007, Immunology and cell biology.
[61] G. Nybakken,et al. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H , 2006, Proceedings of the National Academy of Sciences.
[62] S. Green,et al. Immunopathological mechanisms in dengue and dengue hemorrhagic fever , 2006, Current opinion in infectious diseases.
[63] R. Césaire,et al. Evaluation of an Enzyme Immunoassay for Detection of Dengue Virus NS1 Antigen in Human Serum , 2006, Clinical and Vaccine Immunology.
[64] Yee‐Shin Lin,et al. Autoimmune pathogenesis in dengue virus infection. , 2006, Viral immunology.
[65] S. Vasudevan,et al. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever , 2006, Reviews in medical virology.
[66] P. Brown,et al. Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. , 2006, Biophysical journal.
[67] M. Blettner,et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. , 2006, The Journal of infectious diseases.
[68] A. Talarmin,et al. Secretion of flaviviral non-structural protein NS1: from diagnosis to pathogenesis. , 2006, Novartis Foundation symposium.
[69] C. Thiemermann,et al. Lipoproteins in inflammation and sepsis. I. Basic science , 2006, Intensive Care Medicine.
[70] Sjors H W Scheres,et al. SPI-EM: towards a tool for predicting CATH superfamilies in 3D-EM maps. , 2005, Journal of molecular biology.
[71] I. Kurane,et al. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. , 2004, Journal of virological methods.
[72] C. Thiemermann,et al. High-Density Lipoproteins in Sepsis and Septic Shock: Metabolism, Actions, and Therapeutic Applications , 2004, Shock.
[73] A. Nisalak,et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. , 2002, The Journal of infectious diseases.
[74] J. V. D. van der Meer,et al. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[75] V. Deubel,et al. Enzyme-Linked Immunosorbent Assay Specific to Dengue Virus Type 1 Nonstructural Protein NS1 Reveals Circulation of the Antigen in the Blood during the Acute Phase of Disease in Patients Experiencing Primary or Secondary Infections , 2002, Journal of Clinical Microbiology.
[76] J. Lepault,et al. Dengue Virus Type 1 Nonstructural Glycoprotein NS1 Is Secreted from Mammalian Cells as a Soluble Hexamer in a Glycosylation-Dependent Fashion , 1999, Journal of Virology.
[77] C. Rice,et al. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication , 1997, Journal of virology.
[78] V. Deubel,et al. Purification and renaturation of Japanese encephalitis virus nonstructural glycoprotein NS1 overproduced by insect cells. , 1995, Protein expression and purification.
[79] V. Stollar,et al. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. , 1989, Virology.
[80] J. Schlesinger,et al. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. , 1987, The Journal of general virology.
[81] C. Rice,et al. Molecular biology of the flaviviruses. , 1987, Microbiological sciences.
[82] J. Schlesinger,et al. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. , 1985, Journal of immunology.
[83] R. Cardiff,et al. Dengue Virions and Antigens in Brain and Serum of Infected Mice , 1970, Journal of virology.